Search results

Samples on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.

To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.

ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.

Funding for the reconstructing of Australia’s fire history.

The first National Graduate Innovation Forum will be held in November to connect PhD students with representatives from four of Australia’s leading industries to apply scientific thinking to current real-world challenges. 

ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.

Voucher scheme accelerating medical research

Technical information on the Far Infrared beamline at the Australian Synchrotron.

Highlights of the Magnetism Project.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.

New class of conducting materials found for potential use in next generation fuel cells and other applications.

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.